|
|
Name
|
About
|
|
|
|
Guikai Wu
|
With a BS from
the University of Science & Technology
of China, Hefei, Guikai majored in
Biology. In 2004 from the University of
Texas Health Science Center at San
Antonio, he graduated with a PhD in
Molecular Medicine. His work is focused
on the role of Hec1 in mitosis and the
potential therapeutic application(s) in
breast cancer treatment.
|
 |
|
|
Jiewen Zhu
|
Jiewen received his PhD from Shanghai
Institute of Organic Chemistry. He is
currently synthesizing small molecule
inhibitors of BRCA2-Rad50 and Hec1-Nek2
complexes.
|
 |
|
|
Longen Zhou
|
Longen received
his PhD from Peking Union Medical
University and joined this lab after
working at the National Cancer
Institute, NIH. He is currently working
on small molecule inhibitors which
disrupt BRCA2-Rad51 and Hec1-Nek2
interaction.
|
 |
|
|
Xianzhi Jiang
|
Xianzhi received a BS and MS in
Biochemistry from Sichuan University and
Nanjiang University, respectively. At
the University of Texas Health Science
Center at San Antonio, he received his
PhD in Molecular Medicine. His research
is focused on the function(s) of NPGPx
in redox signaling transduction and
cancer.
|
 |
|
|
Xiaolong Qiu
|
Xiaolong attended
Southwest Normal University in China and
received his BS in Chemistry. He
continued his studies at Shanghai
Institute of Organic Chemistry and
received his PhD in 2005. Currently in
the Lee Lab in collaboration with Prof.
R. Chamberlain, Xiaolong is synthesizing
INH and ZBR2 prodrugs for potential
therapeutic treatments for cancer. |
 |
|
|
Xiaoqin Lin
|
Xiaoqin received her PhD from Ohio
State. Her research interests are to
investigate the biological functions of
Rint-1 (Rad50-interactiong protein).
Another is to investigate the biological
function of a putative novel protein
phosphatase, 15A3, which interacts with
Hec1 protein. |
 |
|
|
Zhanyong Shu
|
Zhanyong, a
specialist in biophysics and
biochemistry, received his PhD from
Dalian Institute of Chemical Physics,
CAS. He is working on the
characterization of cancer-linked
proteins, including SUV3. |
 |